According to TipRanks.com, Risinger is a 2-star analyst with an average return of 2.0% and a 53.3% success rate. Risinger covers the Healthcare sector, focusing on stocks such as Vertex Pharmaceuticals, Horizon Therapeutics, and Theravance Biopharma.
Prometheus Biosciences has an analyst consensus of Strong Buy, with a price target consensus of $52.20.
The company has a one-year high of $51.96 and a one-year low of $19.79. Currently, Prometheus Biosciences has an average volume of 487.8K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Prometheus Biosciences Inc is a biotechnology company pioneering a precision medicine approach to the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment and diagnosis of…
Read More on RXDX: